alovudine has been researched along with Breast Neoplasms in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (22.22) | 29.6817 |
| 2010's | 19 (70.37) | 24.3611 |
| 2020's | 2 (7.41) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, SC; Chang, PH; Hsieh, JC; Huang, JS; Lui, KW; Ng, SH; Su, TP | 1 |
| Byrd, DW; Doot, RK; Kinahan, PE; Krohn, KA; Kurland, BF; Linden, HM; Link, JM; Mankoff, DA; Muzi, M; Novakova-Jiresova, A; Peterson, LM; Romine, PE; Specht, JM | 1 |
| Akoury, J; Ali-Fehmi, R; Eiseler, NT; Heilbrun, LK; Lawhorn-Crews, JM; Shields, AF; Smith, DW; Ueberroth, BE | 1 |
| Cintolo, JA; Pryma, DA; Tchou, J | 1 |
| Barriolo-Riedinger, A; Belly-Poinsignon, A; Bouchet, F; Couturier, O; Djoumessi, F; Ferrer, L; Fourcade, M; Geworski, L; Keros, L; Knoop, BO; Lacoeuille, F; Martin, AL; Martineau, A; Mesleard, C; Millardet, C; Montoya, F; Tendero, K | 1 |
| Aboagye, EO; Bertoldo, A; Rizzo, G; Veronese, M | 1 |
| Ah-See, ML; Amin, V; Beresford, M; Detre, S; Dowsett, M; Li, SP; Makris, A; Miles, D; Sanghera, B; Sonoda, L; Wong, WL; Woolf, DK | 1 |
| Arteaga, CL; Kang, H; Manning, HC; McIntyre, JO; Peterson, TE; Sánchez, V; Whisenant, JG; Yankeelov, TE | 1 |
| Kuo, WH; Shih, TT; Wang, J; Yen, RF | 1 |
| Agresti, R; Alessi, A; Bianchi, G; Bogni, A; Bombardieri, E; Carcangiu, ML; Crippa, F; de Braud, F; Mariani, G; Martelli, G; Maugeri, I; Padovano, B; Pascali, C; Rampa, M; Sandri, M; Trecate, G | 1 |
| Fujiwara, Y; Hamada, A; Hashimoto, J; Kanayama, Y; Kodaira, M; Kurihara, H; Miyakita, Y; Shimizu, C; Tamura, K; Tani, H; Watanabe, Y; Yamamoto, H; Yonemori, K; Yoshida, M; Yunokawa, M | 1 |
| Bear, HD; Cormack, J; Duan, F; Hovanessian-Larsen, L; Idowu, MO; Jolles, PR; Kostakoglu, L; Mallett, S; Mankoff, DA; Miliziano, J; Muzi, JP; Muzi, M; Pryma, DA; Shields, AF; Specht, JM | 1 |
| Kenny, L | 1 |
| Boin, C; Bousquet, G; Cuvier, C; Espié, M; Giacchetti, S; Groheux, D; Hindié, E; Misset, JL; Moretti, JL; Teyton, P | 1 |
| Aboagye, EO; Al-Nahhas, A; Contractor, KB; Coombes, RC; Gray, KR; Kenny, LM; Rosso, L; Shousha, S; Stebbing, J; Turkheimer, FE; Wasan, HS | 1 |
| Berriolo-Riedinger, A; Brunotte, F; Cochet, A; Couturier, O; Girault, S; Rousseau, C | 1 |
| Aboagye, EO; Albarghach, NM; Cheze-Le Rest, C; Hatt, M; Kenny, LM; Metges, JP; Pradier, O; Rosso, L; Turkheimer, FE; Visvikis, D | 1 |
| Aboagye, EO; Al-Nahhas, A; Kenny, LM | 1 |
| Aboagye, EO; Ahmad, R; Al-Nahhas, A; Challapalli, A; Contractor, KB; Coombes, RC; Jacob, J; Kenny, LM; Rosso, L; Sharma, R; Stebbing, J; Turkheimer, F | 1 |
| Direcks, W; Emmering, J; Hoekstra, OS; Lammertsma, AA; Lubberink, M; Molthoff, CF; van der Hoeven, JJ; van Tinteren, H | 1 |
| Aboagye, EO; Challapalli, A; Contractor, K; Coombes, RC; Jacob, J; Stebbing, J | 1 |
| Aboagye, E; Al-Nahhas, A; Challapalli, A; Contractor, K; Coombes, RC; Kenny, L; Mangar, S; Palmieri, C; Riddle, P; Rosso, L; Sharma, R; Stebbing, J; Tomasi, G; Turkheimer, F; Wasan, H | 1 |
| Aboagye, EO; Kenny, LM; Turkheimer, FE; Willaime, JM | 1 |
| Bares, R; Dittmann, H; Dohmen, BM; Fersis, N; Machulla, HJ; Reischl, G; Smyczek-Gargya, B; Vogel, U; Wallwiener, D | 1 |
| Aboagye, EO; Al-Nahhas, A; Coombes, RC; Kenny, LM; Luthra, SK; Osman, S; Shousha, S; Vigushin, DM | 1 |
| Been, LB; Cobben, DC; de Vries, J; Elsinga, PH; Hoekstra, HJ; Jager, PL; Suurmeijer, AJ | 1 |
| Aboagye, EO; Al-Nahhas, A; Coombes, RC; Kenny, L; Shousha, S; Vigushin, DM | 1 |
4 review(s) available for alovudine and Breast Neoplasms
| Article | Year |
|---|---|
Diagnostic and prognostic application of positron emission tomography in breast imaging: emerging uses and the role of PET in monitoring treatment response.
Topics: Breast Neoplasms; Clinical Trials as Topic; Dideoxynucleosides; Early Detection of Cancer; Estradiol; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Treatment Outcome | 2013 |
Molecular imaging using PET for breast cancer.
Topics: Bevacizumab; Breast Neoplasms; Carcinoma, Ductal, Breast; Cetuximab; Dideoxynucleosides; ErbB Receptors; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Molecular Imaging; Norprogesterones; Positron-Emission Tomography; Radiopharmaceuticals; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, Progesterone; Receptors, Vascular Endothelial Growth Factor; Trastuzumab | 2016 |
The Use of Novel PET Tracers to Image Breast Cancer Biologic Processes Such as Proliferation, DNA Damage and Repair, and Angiogenesis.
Topics: Breast Neoplasms; Cell Proliferation; Dideoxynucleosides; DNA Damage; DNA Repair; Female; Humans; Neovascularization, Pathologic; Positron-Emission Tomography; Radiopharmaceuticals | 2016 |
[PET/CT in breast cancer: an update].
Topics: Breast Neoplasms; Carcinoma, Ductal, Breast; Dideoxynucleosides; Estradiol; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sodium Fluoride; Treatment Outcome | 2009 |
5 trial(s) available for alovudine and Breast Neoplasms
| Article | Year |
|---|---|
The use of 3'-deoxy-3'-
Topics: Adult; Breast Neoplasms; Dideoxynucleosides; Disease-Free Survival; Female; Humans; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Prospective Studies; Survival Analysis | 2019 |
A Phase II Study of 3'-Deoxy-3'-18F-Fluorothymidine PET in the Assessment of Early Response of Breast Cancer to Neoadjuvant Chemotherapy: Results from ACRIN 6688.
Topics: Breast Neoplasms; Dideoxynucleosides; Female; Humans; Image Processing, Computer-Assisted; Ki-67 Antigen; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; ROC Curve; Treatment Outcome | 2015 |
[18F]-3'Deoxy-3'-fluorothymidine positron emission tomography and breast cancer response to docetaxel.
Topics: Adult; Aged; Antineoplastic Agents; Breast; Breast Neoplasms; Dideoxynucleosides; Docetaxel; Drug Administration Schedule; Female; Fluorine Radioisotopes; Humans; Kinetics; Middle Aged; Positron-Emission Tomography; Prospective Studies; Taxoids; Time Factors; Treatment Outcome; Tumor Burden | 2011 |
Imaging of cellular proliferation in liver metastasis by [18F]fluorothymidine positron emission tomography: effect of therapy.
Topics: Aged; Breast Neoplasms; Cell Proliferation; Colorectal Neoplasms; Dideoxynucleosides; Female; Humans; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Treatment Outcome | 2012 |
PET with [18F]fluorothymidine for imaging of primary breast cancer: a pilot study.
Topics: Adult; Aged; Breast Neoplasms; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Pilot Projects; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2004 |
18 other study(ies) available for alovudine and Breast Neoplasms
| Article | Year |
|---|---|
Prospective comparison of early interim
Topics: Adult; Aged; Breast Neoplasms; Combined Modality Therapy; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; ROC Curve; Treatment Outcome | 2021 |
Topics: Adult; Aged; Aged, 80 and over; Aromatase Inhibitors; Biomarkers, Tumor; Breast Neoplasms; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Mastectomy; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Estrogen; Treatment Outcome | 2021 |
Calibration test of PET scanners in a multi-centre clinical trial on breast cancer therapy monitoring using 18F-FLT.
Topics: Analysis of Variance; Breast Neoplasms; Calibration; Dideoxynucleosides; Female; Fluorine Radioisotopes; Humans; Multimodal Imaging; Positron-Emission Tomography; Quality Control; Reproducibility of Results; Tomography, X-Ray Computed | 2013 |
Parametric imaging of ¹⁸F-fluoro-3-deoxy-3-L-fluorothymidine PET data to investigate tumour heterogeneity.
Topics: Breast Neoplasms; Dideoxynucleosides; Humans; Image Processing, Computer-Assisted; Positron-Emission Tomography; Reproducibility of Results; Treatment Outcome | 2014 |
Evaluation of FLT-PET-CT as an imaging biomarker of proliferation in primary breast cancer.
Topics: Adult; Aged; Antineoplastic Agents; Biomarkers, Tumor; Breast Neoplasms; Cell Proliferation; Dideoxynucleosides; Female; Humans; Ki-67 Antigen; Mastectomy; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals | 2014 |
Utility of [18 F]FLT-PET to assess treatment response in trastuzumab-resistant and trastuzumab-sensitive HER2-overexpressing human breast cancer xenografts.
Topics: Animals; Antibodies, Monoclonal, Humanized; Breast Neoplasms; Dideoxynucleosides; Drug Design; Drug Resistance, Neoplasm; Female; Humans; Immunohistochemistry; Ki-67 Antigen; Mice; Neoplasm Transplantation; Positron-Emission Tomography; Receptor, ErbB-2; Trastuzumab; Xenograft Model Antitumor Assays | 2015 |
Using (18)F-FLT PET to distinguish between malignant and benign breast lesions with suspicious findings in mammography and breast ultrasound.
Topics: Adult; Aged; Breast; Breast Neoplasms; Dideoxynucleosides; Female; Humans; Mammography; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prone Position; Prospective Studies; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Supine Position; Tomography, X-Ray Computed; Ultrasonography, Mammary; Whole Body Imaging | 2014 |
¹⁸F-FLT PET/CT as an imaging tool for early prediction of pathological response in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy: a pilot study.
Topics: Adult; Breast Neoplasms; Chemotherapy, Adjuvant; Dideoxynucleosides; Female; Humans; Middle Aged; Multimodal Imaging; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Kinetic filtering of [(18)F]Fluorothymidine in positron emission tomography studies.
Topics: Aged; Algorithms; Breast; Breast Neoplasms; Colorectal Neoplasms; Contrast Media; Dideoxynucleosides; Female; Heart; Humans; Kinetics; Linear Models; Liver; Liver Neoplasms; Nonlinear Dynamics; Positron-Emission Tomography; Signal Processing, Computer-Assisted | 2010 |
Bone metastasis of a breast cancer detected by 3'-deoxy-3'-18F-fluorothymidine PET/CT.
Topics: Adult; Bone and Bones; Bone Neoplasms; Breast Neoplasms; Dideoxynucleosides; Docetaxel; Epirubicin; Female; Humans; Positron-Emission Tomography; Taxoids; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
Reproducibility of 18F-FDG and 3'-deoxy-3'-18F-fluorothymidine PET tumor volume measurements.
Topics: Algorithms; Breast Neoplasms; Dideoxynucleosides; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Reproducibility of Results; Tumor Burden | 2010 |
Novel PET biomarkers for breast cancer imaging.
Topics: Biomarkers, Tumor; Breast Neoplasms; Dideoxynucleosides; Estradiol; Female; Fluorodeoxyglucose F18; Humans; Methionine; Positron-Emission Tomography | 2011 |
Validity of simplified 3'-deoxy-3'-[18F]fluorothymidine uptake measures for monitoring response to chemotherapy in locally advanced breast cancer.
Topics: Breast Neoplasms; Dideoxynucleosides; Female; Humans; Neoplasm Staging; Nonlinear Dynamics; Regression Analysis; Statistics as Topic; Treatment Outcome | 2012 |
Monitoring early response to taxane therapy in advanced breast cancer with circulating tumor cells and [(18)F] 3´-deoxy-3´-fluorothymidine PET: a pilot study.
Topics: Breast Neoplasms; Bridged-Ring Compounds; Cell Proliferation; Dideoxynucleosides; Drug Monitoring; Female; Humans; Neoplastic Cells, Circulating; Pilot Projects; Positron-Emission Tomography; Taxoids | 2012 |
Quantification of intra-tumour cell proliferation heterogeneity using imaging descriptors of 18F fluorothymidine-positron emission tomography.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Breast Neoplasms; Cell Proliferation; Dideoxynucleosides; Humans; Kinetics; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Reproducibility of Results; Treatment Failure; Young Adult | 2013 |
Quantification of cellular proliferation in tumor and normal tissues of patients with breast cancer by [18F]fluorothymidine-positron emission tomography imaging: evaluation of analytical methods.
Topics: Breast Neoplasms; Cell Growth Processes; Dideoxynucleosides; Fluorine Radioisotopes; Humans; Ki-67 Antigen; Positron-Emission Tomography; Radiopharmaceuticals | 2005 |
Positron emission tomography in patients with breast cancer using (18)F-3'-deoxy-3'-fluoro-l-thymidine ((18)F-FLT)-a pilot study.
Topics: Adult; Aged; Axilla; Breast Neoplasms; Carcinoma; Dideoxynucleosides; Feasibility Studies; Female; Fluorine Radioisotopes; Humans; Lymph Nodes; Lymphatic Metastasis; Mastectomy; Middle Aged; Pilot Projects; Positron-Emission Tomography; Preoperative Care; Prospective Studies; Reproducibility of Results; Sentinel Lymph Node Biopsy | 2006 |
Imaging early changes in proliferation at 1 week post chemotherapy: a pilot study in breast cancer patients with 3'-deoxy-3'-[18F]fluorothymidine positron emission tomography.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Proliferation; Cyclophosphamide; Dideoxynucleosides; Epirubicin; Female; Fluorouracil; Humans; Ki-67 Antigen; Kinetics; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Treatment Outcome | 2007 |